Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 2, 2003, Pages 473-479

  Steinborn, Andrea ^a   Rebmann, Vera ^b   Scharf, Alexander ^a   Sohn, Christof ^a   Grosse Wilde, Hans ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Abruptio placentae; HELLP (hemolysis, elevated liver enzymes, low platelet count) syndrome; Intrauterine growth retardation; Preeclampsia; Soluble HLA DR molecules

Indexed keywords

HLA DR ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HELLP SYNDROME; HUMAN; IMMUNOSTIMULATION; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY DISORDER; PREMATURE LABOR; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE;

EID: 0037325174     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.55     Document Type: Article

References (29)

1. Shimamura M, Ohta S, Suszuki R, Yamazaki K. Transmission of maternal blood cells to the fetus during pregnancy: detection in mouse neonatal spleen by immunofluorescence flow cytometry and poymerase chain reaction. Blood 1994;83:926-30.
2. Bonney EA, Matzinger P, The maternal immune system's interaction with circulating fetal cells. J Immunol 1997;158:40-7.
3. Wood GW. Is restricted antigen presentation the explanation for fetal allograft survival? Immunol Today 1994;151:15-8.
4. Kelemen K, Paldi A, Tinneberg H, Torok A, Szekeres-Bartho J. Early recognition of pregnancy by the maternal immune system. Am J Reprod Immunol 1998;39:351-5.
5. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ration during normal pregnancy. Clin Exp Immunol 1999;117:550-5.
6. Hammer A, Hutter H, Dohr G. HLA class I expression on the materno-fetal interface. Am J Reprod Immunol 1997;38:150-7.
7. King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK c̀ells. Eur J Immunol 2000;30:1623-31.
8. Moreau P, Paul P, Rouas-Freiss N, Kirszenbaum M, Dausset J, Carosella ED. Molecular and immunologic aspects of the non-classical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft. Am J Reprod Immunol 1998;40:136-44.
9. Harrington K, Cooper D, Lees C, Hecher K, Campbell S. Doppler ultrasound of the uterine spiral arteries: the importance of bilateral notching in the prediction of preeclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 1996;7:182-8.
10. Holzgreve W, Ghezzi F, Di Naro E, Gänshirt D, Maymón E, Hahn S. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998;91:669-72.
11. Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol 1999;41:297-306.
12. Hsu DD, Harirah H, Basherra H, Mor G. Serum soluble Fas levels in preeclampsia. Obstet Gynecol 2001;97:530-2.
13. Allaire A, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol 2000;96:271-6.
14. Ditschkowski E, Freuzfelder E, Rebmann V, Ferencik S, Majetschak M, Schmid EN, et al. HLA-DR expression and soluble HLA-DR levels in sepsis patients after trauma. Ann Surg 1999;229:246-54.
15. Pfeiffer KA, Rebmann V, Pässler M, van der Ven K, van der Ven H, Krebs D, et al. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum Immunol 2000;61:559-64.
16. Westhoff U, Thinnes FP, Götz H, Grosse-Wilde H. Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay. Vox Sang 1991;61:106-10.
17. Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80-6.
18. Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T. Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege. Clin Exp Immunol 2001;123:481-6.
19. Sargent IL, Choo YS, Redman CWG. Isolating and analyzing fetal leukocytes in maternal blood. Ann NY Acad Sci 1994;731:147-53.
20. Reed E, Beer AE, Hutcherson H, King DW, Suciu-Foca N. The alloantibody response of pregnant women and its suppression by soluble HLA antigens and anti-idiotypic antibodies. J Reprod Immunol 1991;20:115-26.
21. Nicolle MW, Nag B, Sharma SD, Willcox N, Vincent A, Ferguson DJ, and Newsom-Davis J. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest 1994;93:1361-9.
22. Barden A, Graham D, Beilin LJ, Bake R, Ritchie J, Michael CA, et al. Cd11b expression on circulating neutrophiles in preeclampsia. Clin Sci 1997;92:37-44.
23. Redman CWG, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
24. Matthiesen L, Ekerfelt C, Berg G, Ernerudh J. Increased numbers of circulating interferon-gamma and interleukin-4 secreting cells during normal pregnancy. Am J Reprod Immunol 1998;39:362-7.
25. Lo YMS, Leung TN, Tein MSC, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;2:184-8.
26. Zhong XY, Holzgreve W, Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002;21:77-83.
27. Filaci G, Contini P, Brenci S, Lanza L, Scudeletti M, Indiveri F, et al. Increased serum concentrations of soluble HLA-DR antigens in HIV infection and following transplantation. Tissue Antigens 1995;46:117-23.
28. von Tempelhoff GF, Heilmann L, Spanuth E, Kunzmann E, Hommel G. Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphopholipid-antibodies in patients with preeclampsia or HELLP-syndrome. Thromb Res 2000;100:363-5.
29. Branch DW, Porter TF, Rittenhouse L, Caritis S, Sibai B, Hogg B, et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001;184:825-32.